Plavix News
Most Popular Plavix Story
FDA turns thumbs down on Multaq
Sanofi-Aventis says that the FDA has rejected its heart drug Multaq (dronedarone), evidently unsatisfied with the data provided to support its application. Multaq is designed to treat atrial fibrillation. Sanofi-Aventis hasn't given up on the drug, though. The company says it plans to refile for approval in the first half of 2008, after it receives a fresh batch of data from an ongoing study. Last February the FDA rejected Sanofi-Aventis' bid to market Acomplia. And analysts weren't happy …
... Read more...Latest Headlines
- May 13, 2008
- March 31, 2008
- February 22, 2008
- January 4, 2008
- November 28, 2007
- November 21, 2007
- November 19, 2007
- November 5, 2007
- October 25, 2007
- June 25, 2007
- June 25, 2007
- January 28, 2007
- November 6, 2006
- October 25, 2006
- September 11, 2006
- September 10, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
